TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Nutriband Inc.
Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch

Nutriband met with the FDA to discuss its AVERSA™ FENTANYL abuse deterrent patch, receiving guidance on regulatory pathway, manufacturing, and clinical study plans for a potential first-of-its-kind worldwide abuse deterrent fentanyl patch.

Insights
NKE   negative

Experiencing significant sales slowdown, market share challenges, and underperforming with flattened revenue and pressured margins


NTRB   positive

Company received constructive FDA feedback, moving forward with development of innovative abuse deterrent technology with potential market value of $80-200 million